Filed: Sep. 27, 2018
Latest Update: Sep. 27, 2018
Summary: STIPULATION AND [PROPOSED] REVISED SCHEDULING ORDER CONCERNING DEFENDANT'S REPLY IN SUPPORT OF ITS PENDING MOTION TO DISMISS AND HEARING REGARDING THE SAME RICHARD SEEBORG , District Judge . Pursuant to Civil Local Rule 7-2, 7-3, 7-7, and 7-12, Parties to the above-entitled action, by and through their undersigned counsel, hereby stipulate to the following: 1. An order granting a Stay in the above-titled action was issued on May 4, 2018 pursuant to 28 U.S.C. 1659(a). This order suspe
Summary: STIPULATION AND [PROPOSED] REVISED SCHEDULING ORDER CONCERNING DEFENDANT'S REPLY IN SUPPORT OF ITS PENDING MOTION TO DISMISS AND HEARING REGARDING THE SAME RICHARD SEEBORG , District Judge . Pursuant to Civil Local Rule 7-2, 7-3, 7-7, and 7-12, Parties to the above-entitled action, by and through their undersigned counsel, hereby stipulate to the following: 1. An order granting a Stay in the above-titled action was issued on May 4, 2018 pursuant to 28 U.S.C. 1659(a). This order suspen..
More
STIPULATION AND [PROPOSED] REVISED SCHEDULING ORDER CONCERNING DEFENDANT'S REPLY IN SUPPORT OF ITS PENDING MOTION TO DISMISS AND HEARING REGARDING THE SAME
RICHARD SEEBORG, District Judge.
Pursuant to Civil Local Rule 7-2, 7-3, 7-7, and 7-12, Parties to the above-entitled action, by and through their undersigned counsel, hereby stipulate to the following:
1. An order granting a Stay in the above-titled action was issued on May 4, 2018 pursuant to 28 U.S.C. 1659(a). This order suspended all filing deadlines relevant to this matter, and has not yet been superseded.
2. As such, Parties to this action hereby stipulate to the proposed schedule for case-specific deadlines for Valeant Pharmaceuticals NA, LLC v. ECI Pharmaceuticals LLC, 3:18-cv-00355-RS:
Event Date
Deadline for Defendant's Reply in Support of its October 12, 2018
Motion to Dismiss
Joint Hearing on Defendant's Motion to Dismiss October 25, 2018 1:30 pm PST
Courtroom 03, 17th Floor
3. Consequently, the Parties to this action formally request a Joint Hearing on Defendant's Motion to Dismiss at the same time as the hearing for the Virtus Defendants has been ordered in Valeant Pharmaceuticals North America LLC v. Virtus Pharmaceuticals, LLC & Virtus Pharmaceuticals OPCO II, LLC, Case No. 3:17-cv-06731-RS at D.E. 77. Namely, that the Joint Hearing take place on October 25, 2018 at 1:30 p.m., Courtroom 3, 17th Floor.
4. The Defendant's motions to dismiss present certain common issues of fact and law. The Parties to this action therefore believe that conducting this hearing in conjunction with the hearing on Virtus Defendants' motions will promote efficiency and judicial economy.
[PROPOSED] ORDER
PURSUANT TO STIPULATION, IT IS SO ORDERED.
